Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2023 Filed Mar 18, 2023 00:01 UTC |
LONDON SARAHDirector · Chief Executive Officer
|
GrantCommon Stock | 217,082 | $63.34 | $13,749,973.88 |
DisclosureSEC source: 0001071739-23-000066 · wf-form4_167909766664317.xml · nonDerivative · entry 1 LONDON SARAH · CIK 0001845762 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,035 F1 · balance_after: Ownership includes this award of 217,082 restricted stock units. 141,103 units are performance stock units. The number of performance stock units vesting at the end of the three year period is predicated on meeting three-year performance conditions. The remaining 75,979 units will vest in three annual installments on the anniversary of the grant date. In addition, ownership includes 285,670 shares of restricted stock units subject to vesting requirements. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 21:53 UTC |
FASOLA KENNETH JPresident
|
GrantPhantom Stock · Derivative | 3,311.497 | $65.54 Strike: $0.00 | $217,035.51 |
DisclosureSEC source: 0001071739-23-000057 · wf-form4_167883077904676.xml · derivative · entry 2 FASOLA KENNETH J · CIK 0001030150 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,605.628 Underlying: Common Stock · 3,311.497 shares Expires 2023-03-10 F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. F3 · shares: The phantom stock was acquired by Mr. Fasola through regularly scheduled payroll contributions to the Company's deferred compensation plan. F4 · derivative.expiration_date: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Fasola's termination with the Company, or on such other date Mr. Fasola may elect. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 19:55 UTC |
MURRAY JAMES EEVP, Chief Operating Officer
|
GrantPhantom Stock · Derivative | 25.234 | $68.59 Strike: $0.00 | $1,730.80 |
DisclosureSEC source: 0001071739-23-000055 · wf-form4_167815054325457.xml · derivative · entry 3 MURRAY JAMES E · CIK 0001018658 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118.007 Underlying: Phantom Stock · 25.234 shares Expires 2023-03-03 F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. F3 · shares: The phantom stock was acquired by Mr. Murray through regularly scheduled payroll contributions to the Company's deferred compensation plan. F4 · derivative.expiration_date: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Murray's termination with the Company or on such other date Mr. Murray may elect. Read SEC document |
| March 02, 2023 Filed Mar 7, 2023 00:55 UTC |
Asher Andrew LynnEVP, CFO
|
Tax withholdingCommon Stock | 2,227 | $68.51 | $152,571.77 |
DisclosureSEC source: 0001071739-23-000054 · wf-form4_167815052695529.xml · nonDerivative · entry 1 Asher Andrew Lynn · CIK 0001617763 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,528.48 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 166,973 shares of restricted stock subject to vesting requirements. Read SEC document |
| February 28, 2023 Filed Mar 3, 2023 01:06 UTC |
LONDON SARAHDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 2,523 | $70.09 | $176,837.07 |
DisclosureSEC source: 0001071739-23-000051 · wf-form4_167780558752173.xml · nonDerivative · entry 1 LONDON SARAH · CIK 0001845762 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,953 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 285,670 shares of restricted stock subject to vesting requirements. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 18:18 UTC |
MURRAY JAMES EEVP, Chief Operating Officer
|
GrantPhantom Stock · Derivative | 23.706 | $73.01 Strike: $0.00 | $1,730.78 |
DisclosureSEC source: 0001071739-23-000049 · wf-form4_167702147407452.xml · derivative · entry 3 MURRAY JAMES E · CIK 0001018658 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92.773 Underlying: Phantom Stock · 23.706 shares Expires 2023-02-17 F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. F3 · shares: The phantom stock was acquired by Mr. Murray through regularly scheduled payroll contributions to the Company's deferred compensation plan. F4 · derivative.expiration_date: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Murray's termination with the Company or on such other date Mr. Murray may elect. Read SEC document |
| February 10, 2023 Filed Feb 10, 2023 20:00 UTC |
Asher Andrew LynnEVP, CFO
|
PurchaseCommon Stock | 3,800 | $71.97 | $273,486.00 |
DisclosureSEC source: 0001071739-23-000039 · wf-form4_167605921391498.xml · nonDerivative · entry 2 Asher Andrew Lynn · CIK 0001617763 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,755.48 F3 · price: The weighted average price for this transaction is reported within the form. Shares were purchased at prices ranging from $71.96 to $71.99. Full information regarding the number of shares at each price is available upon request. Read SEC document |
| February 09, 2023 Filed Feb 10, 2023 20:00 UTC |
Asher Andrew LynnEVP, CFO
|
PurchaseCommon Stock | 3,000 | $71.89 | $215,670.00 |
DisclosureSEC source: 0001071739-23-000039 · wf-form4_167605921391498.xml · nonDerivative · entry 1 Asher Andrew Lynn · CIK 0001617763 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,955.48 F1 · price: The weighted average price for this transaction is reported within the form. Shares were purchased at prices ranging from $71.85 to $71.91. Full information regarding the number of shares at each price is available upon request. F2 · balance_after: Ownership includes 172,632 shares of restricted stock subject to vesting requirements. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 17:07 UTC |
MURRAY JAMES EEVP, Chief Operating Officer
|
PurchaseCommon Stock | 6,750 | $73.30 | $494,775.00 |
DisclosureSEC source: 0001071739-23-000030 · wf-form4_167598045096542.xml · nonDerivative · entry 1 MURRAY JAMES E · CIK 0001018658 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,220 F1 · price: The weighted average price for this transaction is reported within the form. Shares were purchased at prices ranging from $73.25 to $73.36. Full information regarding the number of shares at each price is available upon request. F2 · balance_after: Ownership includes 100,761 shares of restricted stock subject to vesting requirements. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 22:07 UTC |
Samuels Theodore R. IIDirector
|
PurchaseCommon Stock | 7,000 | $71.88 | $503,160.00 |
DisclosureSEC source: 0001071739-23-000029 · wf-form4_167598042905213.xml · nonDerivative · entry 1 Samuels Theodore R. II · CIK 0001688276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,912.5 F1 · price: The weighted average price for this transaction is reported within the form. Shares were purchased at prices ranging from $71.86 to $71.89. Full information regarding the number of shares at each price is available upon request. F2 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 02:20 UTC |
KOSTER CHRISTOPHEREVP, Secr. & General Counsel
|
Tax withholdingCommon Stock | 6,175 | $71.01 | $438,486.75 |
DisclosureSEC source: 0001071739-23-000035 · wf-form4_167599562236762.xml · nonDerivative · entry 2 KOSTER CHRISTOPHER · CIK 0001802501 · EVP, Secr. & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,073.15 F2 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F3 · balance_after: Ownership includes 68,980 shares of restricted stock subject to vesting requirements. F4 · balance_after: Updated ownership includes common stock acquired through the Company's Employee Stock Purchase Program. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 02:20 UTC |
KOSTER CHRISTOPHEREVP, Secr. & General Counsel
|
GrantCommon Stock | 324 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000035 · wf-form4_167599562236762.xml · nonDerivative · entry 1 KOSTER CHRISTOPHER · CIK 0001802501 · EVP, Secr. & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,248.15 F1 · shares: Represents the additional number of shares earned from a previously reported performance stock unit grant from December 2019 with a three-year performance period. Refer to Form 3 filed on February 10, 2020. 13,500 shares were reported based on achievement of target level of performance. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 02:20 UTC |
Asher Andrew LynnEVP, CFO
|
Tax withholdingCommon Stock | 10,287 | $71.01 | $730,479.87 |
DisclosureSEC source: 0001071739-23-000036 · wf-form4_167599564274352.xml · nonDerivative · entry 2 Asher Andrew Lynn · CIK 0001617763 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,955.48 F2 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F3 · balance_after: Ownership includes 172,632 shares of restricted stock subject to vesting requirements. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 02:20 UTC |
Asher Andrew LynnEVP, CFO
|
GrantCommon Stock | 611 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000036 · wf-form4_167599564274352.xml · nonDerivative · entry 1 Asher Andrew Lynn · CIK 0001617763 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,242.48 F1 · shares: Represents the additional number of shares earned from a previously reported performance stock unit grant from March 2020 with a three-year performance period. Refer to Form 3 filed on May 11, 2021. 25,462 shares were reported based on achievement of target level of performance. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 02:20 UTC |
Burdick Kenneth ADirector
|
Tax withholdingCommon Stock | 29,922 | $71.01 | $2,124,761.22 |
DisclosureSEC source: 0001071739-23-000034 · wf-form4_167599560206071.xml · nonDerivative · entry 2 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,289.284 F2 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F3 · balance_after: Ownership includes 72,639 shares of restricted stock units subject to vesting requirements. Read SEC document |
| February 07, 2023 Filed Feb 10, 2023 02:20 UTC |
Burdick Kenneth ADirector
|
GrantCommon Stock | 1,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000034 · wf-form4_167599560206071.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,211.284 F1 · shares: Represents the additional number of shares earned from a previously reported performance stock unit grant from March 2020 with a three-year performance period. Refer to Form 4 filed on March 4, 2020. 79,215 shares were reported based on achievement of target level of performance. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:01 UTC |
MURRAY JAMES EEVP, Chief Operating Officer
|
GrantPhantom Stock · Derivative | 23.85 | $72.57 Strike: $0.00 | $1,730.79 |
DisclosureSEC source: 0001071739-23-000026 · wf-form4_167582169844240.xml · derivative · entry 3 MURRAY JAMES E · CIK 0001018658 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69.067 Underlying: Phantom Stock · 23.85 shares Expires 2023-02-03 F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. F3 · shares: The phantom stock was acquired by Mr. Murray through regularly scheduled payroll contributions to the Company's deferred compensation plan. F4 · derivative.expiration_date: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Murray's termination with the Company or on such other date Mr. Murray may elect. Read SEC document |
| January 20, 2023 Filed Jan 23, 2023 19:47 UTC |
MURRAY JAMES EEVP, Chief Operating Officer
|
GrantPhantom Stock · Derivative | 22.815 | $75.86 Strike: $0.00 | $1,730.75 |
DisclosureSEC source: 0001071739-23-000022 · wf-form4_167452123041474.xml · derivative · entry 3 MURRAY JAMES E · CIK 0001018658 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45.217 Underlying: Phantom Stock · 22.815 shares Expires 2023-01-20 F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. F3 · shares: The phantom stock was acquired by Mr. Murray through regularly scheduled payroll contributions to the Company's deferred compensation plan. F4 · derivative.expiration_date: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Murray's termination with the Company or on such other date Mr. Murray may elect. Read SEC document |
| January 19, 2023 Filed Jan 24, 2023 00:47 UTC |
FASOLA KENNETH JPresident
|
Tax withholdingCommon Stock | 7,055 | $75.09 | $529,759.95 |
DisclosureSEC source: 0001071739-23-000021 · wf-form4_167452120496920.xml · nonDerivative · entry 1 FASOLA KENNETH J · CIK 0001030150 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,481 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 143,752 shares of restricted stock subject to vesting requirements. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 19:53 UTC |
MURRAY JAMES EEVP, Chief Operating Officer
|
GrantPhantom Stock · Derivative | 22.402 | $77.26 Strike: $0.00 | $1,730.78 |
DisclosureSEC source: 0001071739-23-000018 · wf-form4_167339839473377.xml · derivative · entry 3 MURRAY JAMES E · CIK 0001018658 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22.402 Underlying: Phantom Stock · 22.402 shares Expires 2023-01-06 F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. F3 · shares: The phantom stock was acquired by Mr. Murray through regularly scheduled payroll contributions to the Company's deferred compensation plan. F4 · derivative.expiration_date: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Murray's termination with the Company or on such other date Mr. Murray may elect. Read SEC document |
| December 31, 2022 Filed Jan 5, 2023 00:08 UTC |
FORD MONTE EDirector
|
GrantCommon Stock | 203.771 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000016 · wf-form4_167287731684204.xml · nonDerivative · entry 1 FORD MONTE E · CIK 0001085361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,392.771 F1 · balance_after: Ownership includes 1,189 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 31, 2022 Filed Jan 5, 2023 00:08 UTC |
Burdick Kenneth ADirector
|
GrantCommon Stock | 428.501 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000014 · wf-form4_167287726032655.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,310.284 F1 · balance_after: Ownership includes 151,854 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 31, 2022 Filed Jan 5, 2023 00:08 UTC |
DeVeydt Wayne SDirector
|
GrantCommon Stock | 382.591 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000015 · wf-form4_167287729218250.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,912.5 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 31, 2022 Filed Jan 5, 2023 00:06 UTC |
COUGHLIN CHRISTOPHER JDirector
|
GrantCommon Stock | 443.805 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000012 · wf-form4_167287719929148.xml · nonDerivative · entry 1 COUGHLIN CHRISTOPHER J · CIK 0001110750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,150.818 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 31, 2022 Filed Jan 5, 2023 00:07 UTC |
Dallas H JamesDirector
|
GrantCommon Stock | 459.109 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000013 · wf-form4_167287721863577.xml · nonDerivative · entry 1 Dallas H James · CIK 0001324953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,911.942 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 31, 2022 Filed Jan 5, 2023 00:06 UTC |
Samuels Theodore R. IIDirector
|
GrantCommon Stock | 382.591 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000011 · wf-form4_167287717290152.xml · nonDerivative · entry 1 Samuels Theodore R. II · CIK 0001688276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,912.5 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 31, 2022 Filed Jan 5, 2023 00:06 UTC |
TRUBECK WILLIAM LDirector
|
GrantCommon Stock | 474.412 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000010 · wf-form4_167287714998906.xml · nonDerivative · entry 1 TRUBECK WILLIAM L · CIK 0001103609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,601.521 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 31, 2022 Filed Jan 5, 2023 00:05 UTC |
EPPINGER FREDERICK HDirector
|
GrantCommon Stock | 382.591 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000009 · wf-form4_167287712851293.xml · nonDerivative · entry 1 EPPINGER FREDERICK H · CIK 0001261155 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,919.179 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| December 23, 2022 Filed Dec 28, 2022 23:06 UTC |
FASOLA KENNETH JPresident
|
GrantPhantom Stock · Derivative | 24.319 | $82.24 Strike: $0.00 | $1,999.99 |
DisclosureSEC source: 0001071739-22-000399 · wf-form4_167226877198123.xml · derivative · entry 2 FASOLA KENNETH J · CIK 0001030150 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294.131 Underlying: Common Stock · 24.319 shares Expires 2022-12-23 F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. F3 · shares: The phantom stock was acquired by Mr. Fasola through regularly scheduled payroll contributions to the Company's deferred compensation plan. F4 · derivative.expiration_date: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Fasola's termination with the Company, or on such other date Mr. Fasola may elect. Read SEC document |
| December 21, 2022 Filed Feb 15, 2023 00:07 UTC |
GEPHARDT Richard ADirector
|
GiftCommon Stock | 1,655 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-23-000041 · wf-form5_167641961360936.xml · nonDerivative · entry 1 GEPHARDT Richard A · CIK 0001324629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,905.43 F1 · balance_after: Ownership includes 2,323 shares of restricted stock subject to vesting requirements. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 23:55 UTC |
KOSTER CHRISTOPHEREVP, Secr. & General Counsel
|
Tax withholdingCommon Stock | 4,928 | $83.00 | $409,024.00 |
DisclosureSEC source: 0001071739-22-000395 · wf-form4_167149408897841.xml · nonDerivative · entry 1 KOSTER CHRISTOPHER · CIK 0001802501 · EVP, Secr. & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,892.062 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 82,480 shares of restricted stock subject to vesting requirements. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 23:55 UTC |
Asher Andrew LynnEVP, CFO
|
Tax withholdingCommon Stock | 4,548 | $83.00 | $377,484.00 |
DisclosureSEC source: 0001071739-22-000396 · wf-form4_167149411197216.xml · nonDerivative · entry 1 Asher Andrew Lynn · CIK 0001617763 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,631.48 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 198,094 shares of restricted stock subject to vesting requirements. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 23:54 UTC |
LONDON SARAHDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 5,160 | $83.00 | $428,280.00 |
DisclosureSEC source: 0001071739-22-000394 · wf-form4_167149407095960.xml · nonDerivative · entry 1 LONDON SARAH · CIK 0001845762 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,476 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 291,364 shares of restricted stock subject to vesting requirements. Read SEC document |
| December 10, 2022 Filed Dec 13, 2022 23:56 UTC |
KOSTER CHRISTOPHEREVP, Secr. & General Counsel
|
Tax withholdingCommon Stock | 1,340 | $86.25 | $115,575.00 |
DisclosureSEC source: 0001071739-22-000384 · wf-form4_167097577226107.xml · nonDerivative · entry 1 KOSTER CHRISTOPHER · CIK 0001802501 · EVP, Secr. & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,820.062 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 93,514 shares of restricted stock subject to vesting requirements. F3 · balance_after: Updated ownership includes common stock acquired through the Company's Employee Stock Purchase Program. Read SEC document |
| December 10, 2022 Filed Dec 13, 2022 23:57 UTC |
LAYTON BRENT DPresident & COO
|
Tax withholdingCommon Stock | 2,985 | $86.25 | $257,456.25 |
DisclosureSEC source: 0001071739-22-000385 · wf-form4_167097583228351.xml · nonDerivative · entry 1 LAYTON BRENT D · CIK 0001731041 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,852.609 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 325,127 shares of restricted stock subject to vesting requirements. F3 · balance_after: Updated ownership includes common stock acquired through the Company's Employee Stock Purchase Program. Read SEC document |
| December 10, 2022 Filed Dec 13, 2022 23:50 UTC |
CASSO KATIESVP, Corporate Controller, CAO
|
Tax withholdingCommon Stock | 755 | $86.25 | $65,118.75 |
DisclosureSEC source: 0001071739-22-000381 · wf-form4_167097541780273.xml · nonDerivative · entry 1 CASSO KATIE · CIK 0001853379 · SVP, Corporate Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,169 F1 · shares: Shares withheld for taxes upon vesting of previously reported stock grant. F2 · balance_after: Ownership includes 16,008 shares of restricted stock subject to vesting requirements. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 23:52 UTC |
FORD MONTE EDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $86.49 | $0.00 |
DisclosureSEC source: 0001071739-22-000383 · wf-form4_167097554536408.xml · derivative · entry 2 FORD MONTE E · CIK 0001085361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-12-09 F2 · derivative.exercise_date: The options vest in three equal installments on the anniversary of the grant beginning on December 9, 2023. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 23:52 UTC |
FORD MONTE EDirector
|
GrantCommon Stock | 1,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-22-000383 · wf-form4_167097554536408.xml · nonDerivative · entry 1 FORD MONTE E · CIK 0001085361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,189 F1 · balance_after: Ownership includes 1,189 shares of restricted stock vesting on the date of the 2023 Annual Meeting of Stockholders. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 23:51 UTC |
FASOLA KENNETH JEVP, Health Care Enterprises
|
GrantPhantom Stock · Derivative | 44.096 | $86.49 Strike: $0.00 | $3,813.86 |
DisclosureSEC source: 0001071739-22-000382 · wf-form4_167097548272074.xml · derivative · entry 2 FASOLA KENNETH J · CIK 0001030150 · EVP, Health Care Enterprises 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269.812 Underlying: Common Stock · 44.096 shares Expires 2022-12-09 F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. F3 · shares: The phantom stock was acquired by Mr. Fasola through regularly scheduled payroll contributions to the Company's deferred compensation plan. F4 · derivative.expiration_date: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Fasola's termination with the Company, or on such other date Mr. Fasola may elect. Read SEC document |
| November 25, 2022 Filed Nov 30, 2022 00:00 UTC |
FASOLA KENNETH JEVP, Health Care Enterprises
|
GrantPhantom Stock · Derivative | 23.915 | $83.63 Strike: $0.00 | $2,000.01 |
DisclosureSEC source: 0001071739-22-000375 · wf-form4_166976641454902.xml · derivative · entry 2 FASOLA KENNETH J · CIK 0001030150 · EVP, Health Care Enterprises 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225.716 Underlying: Common Stock · 23.915 shares Expires 2022-11-25 F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. F3 · shares: The phantom stock was acquired by Mr. Fasola through regularly scheduled payroll contributions to the Company's deferred compensation plan. F4 · derivative.expiration_date: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Fasola's termination with the Company, or on such other date Mr. Fasola may elect. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 23:41 UTC |
FASOLA KENNETH JEVP, Health Care Enterprises
|
GrantPhantom Stock · Derivative | 23.843 | $83.88 Strike: $0.00 | $1,999.95 |
DisclosureSEC source: 0001071739-22-000366 · wf-form4_166855568264696.xml · derivative · entry 2 FASOLA KENNETH J · CIK 0001030150 · EVP, Health Care Enterprises 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201.801 Underlying: Common Stock · 23.843 shares Expires 2022-11-10 F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. F3 · shares: The phantom stock was acquired by Mr. Fasola through regularly scheduled payroll contributions to the Company's deferred compensation plan. F4 · derivative.expiration_date: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Fasola's termination with the Company, or on such other date Mr. Fasola may elect. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 23:20 UTC |
FASOLA KENNETH JEVP, Health Care Enterprises
|
GrantPhantom Stock · Derivative | 23.79 | $84.07 Strike: $0.00 | $2,000.03 |
DisclosureSEC source: 0001071739-22-000364 · wf-form4_166734478692149.xml · derivative · entry 2 FASOLA KENNETH J · CIK 0001030150 · EVP, Health Care Enterprises 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177.958 Underlying: Common Stock · 23.79 shares Expires 2022-10-28 F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. F3 · shares: The phantom stock was acquired by Mr. Fasola through regularly scheduled payroll contributions to the Company's deferred compensation plan. F4 · derivative.expiration_date: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Fasola's termination with the Company, or on such other date Mr. Fasola may elect. Read SEC document |
| October 14, 2022 Filed Oct 18, 2022 23:36 UTC |
FASOLA KENNETH JEVP, Health Care Enterprises
|
GrantPhantom Stock · Derivative | 26.575 | $75.26 Strike: $0.00 | $2,000.03 |
DisclosureSEC source: 0001071739-22-000354 · wf-form4_166613615103995.xml · derivative · entry 2 FASOLA KENNETH J · CIK 0001030150 · EVP, Health Care Enterprises 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154.168 Underlying: Common Stock · 26.575 shares Expires 2022-10-14 F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. F3 · shares: The phantom stock was acquired by Mr. Fasola through regularly scheduled payroll contributions to the Company's deferred compensation plan. F4 · derivative.expiration_date: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Fasola's termination with the Company, or on such other date Mr. Fasola may elect. Read SEC document |
| September 30, 2022 Filed Oct 5, 2022 01:29 UTC |
DeVeydt Wayne SDirector
|
GrantCommon Stock | 349.67 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-22-000345 · wf-form4_166493208080854.xml · nonDerivative · entry 1 DeVeydt Wayne S · CIK 0001321392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,529.909 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| September 30, 2022 Filed Oct 5, 2022 01:20 UTC |
Dallas H JamesDirector
|
GrantCommon Stock | 419.604 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-22-000347 · wf-form4_166493210363027.xml · nonDerivative · entry 1 Dallas H James · CIK 0001324953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,452.833 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| September 30, 2022 Filed Oct 5, 2022 01:18 UTC |
COUGHLIN CHRISTOPHER JDirector
|
GrantCommon Stock | 405.617 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-22-000346 · wf-form4_166493209167142.xml · nonDerivative · entry 1 COUGHLIN CHRISTOPHER J · CIK 0001110750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,707.013 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| September 30, 2022 Filed Oct 5, 2022 01:18 UTC |
TRUBECK WILLIAM LDirector
|
GrantCommon Stock | 433.591 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-22-000344 · wf-form4_166493206949784.xml · nonDerivative · entry 1 TRUBECK WILLIAM L · CIK 0001103609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,127.109 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| September 30, 2022 Filed Oct 5, 2022 01:18 UTC |
FASOLA KENNETH JEVP, Health Care Enterprises
|
GrantPhantom Stock · Derivative | 26.162 | $77.68 Strike: $0.00 | $2,032.26 |
DisclosureSEC source: 0001071739-22-000350 · wf-form4_166493258018104.xml · derivative · entry 2 FASOLA KENNETH J · CIK 0001030150 · EVP, Health Care Enterprises 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127.593 Underlying: Common Stock · 26.162 shares Expires 2022-09-30 F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive the fair market value of one share of Centene common stock. F3 · shares: The phantom stock was acquired by Mr. Fasola through regularly scheduled payroll contributions to the Company's deferred compensation plan. F4 · derivative.expiration_date: The phantom stock has no formal expiration date. The phantom stock will be settled in cash or other non-Company securities upon Mr. Fasola's termination with the Company, or on such other date Mr. Fasola may elect. Read SEC document |
| September 30, 2022 Filed Oct 5, 2022 01:10 UTC |
Samuels Theodore R. IIDirector
|
GrantCommon Stock | 349.67 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-22-000349 · wf-form4_166493214115531.xml · nonDerivative · entry 1 Samuels Theodore R. II · CIK 0001688276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,529.909 F1 · balance_after: Ownership includes 2,323 shares of restricted stock units subject to vesting requirements. Read SEC document |
| September 30, 2022 Filed Oct 5, 2022 01:10 UTC |
Burdick Kenneth ADirector
|
GrantCommon Stock | 366.544 | $0.00 | $0.00 |
DisclosureSEC source: 0001071739-22-000348 · wf-form4_166493213112361.xml · nonDerivative · entry 1 Burdick Kenneth A · CIK 0001498992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,881.783 F1 · balance_after: Ownership includes 151,854 shares of restricted stock units subject to vesting requirements. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.